天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2014年
8期
825-826,827
,共3页
宋庆宏%李阳春%赵奇%栗力
宋慶宏%李暘春%趙奇%慄力
송경굉%리양춘%조기%률력
动脉硬化,闭塞性%下肢%VIABAHN覆膜支架%血管腔内成形术%膨体聚四氟乙烯
動脈硬化,閉塞性%下肢%VIABAHN覆膜支架%血管腔內成形術%膨體聚四氟乙烯
동맥경화,폐새성%하지%VIABAHN복막지가%혈관강내성형술%팽체취사불을희
arteriosclerosis obliterans%lower extremity%VIABAHN-covered stent%percutaneous transluminal angio-plasty%expanded polytetrafluoroethylene
目的:探讨VIABAHN覆膜支架对下肢动脉硬化闭塞症的中短期疗效。方法53例下肢动脉硬化闭塞症患者,其中22例行VIABAHN覆膜支架治疗(支架组),31例行传统股-腘搭桥手术(搭桥组),分析2组术后3、6个月的通畅率。结果搭桥组术后3、6个月通畅分别为28例(90.3%)、26例(83.9%)。支架组术后3、6个月通畅分别为22例(100%)、21例(95.5%)。2组术后3、6个月通畅率差异无统计学意义(χ2分别为0.808和0.760,P>0.05)。结论 VIABAHN覆膜支架可作为近关节下肢动脉硬化闭塞症的首选治疗方法。
目的:探討VIABAHN覆膜支架對下肢動脈硬化閉塞癥的中短期療效。方法53例下肢動脈硬化閉塞癥患者,其中22例行VIABAHN覆膜支架治療(支架組),31例行傳統股-腘搭橋手術(搭橋組),分析2組術後3、6箇月的通暢率。結果搭橋組術後3、6箇月通暢分彆為28例(90.3%)、26例(83.9%)。支架組術後3、6箇月通暢分彆為22例(100%)、21例(95.5%)。2組術後3、6箇月通暢率差異無統計學意義(χ2分彆為0.808和0.760,P>0.05)。結論 VIABAHN覆膜支架可作為近關節下肢動脈硬化閉塞癥的首選治療方法。
목적:탐토VIABAHN복막지가대하지동맥경화폐새증적중단기료효。방법53례하지동맥경화폐새증환자,기중22례행VIABAHN복막지가치료(지가조),31례행전통고-객탑교수술(탑교조),분석2조술후3、6개월적통창솔。결과탑교조술후3、6개월통창분별위28례(90.3%)、26례(83.9%)。지가조술후3、6개월통창분별위22례(100%)、21례(95.5%)。2조술후3、6개월통창솔차이무통계학의의(χ2분별위0.808화0.760,P>0.05)。결론 VIABAHN복막지가가작위근관절하지동맥경화폐새증적수선치료방법。
Objective To evaluate short and medium term therapeutic effects of VIABAHN-covered stent in treat-ment of arteriosclerosis obliterans in lower extremity. Methods Among all 53 cases of arteriosclerosis obliterans in lower extremity with C/D TASC levels, 22 patients underwent VIABAHN-covered stent (stent group), while the other 31 patients were treated with femoral-popliteal artery bypass grafting surgery (graft group). The arterial patency rates were analyzed 3 and 6 months after the two different surgeries. Results The number of arterial patency cases were 28 (90.3%) at 3 months and 26 (83.9%) at 6 months in stent group while it is 22 (100%) at 3 months and 21 (95.5%) at 6 months in graft group. There were no significant differences in the arterial patency rate at 3 months and 6 months between the two different surger-ies (χ2 is 0.808 and 0.760 respectively, P>0.05). Conclusion VIABAHN-covered stent can be used as the preferred treat-ment for arteriosclerosis obliterans of lower extremity.